share_log

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K：員工持股年度報告
美股sec公告 ·  06/25 16:26
Moomoo AI 已提取核心訊息
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial performance of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, which is a defined contribution retirement plan for its employees. The plan includes a variety of investment options and is subject to ERISA provisions. The financial statements, audited by Withum Smith + Brown, PC, indicate that the plan's net assets available for benefits decreased from $62,527,000 at the beginning of the year to $60,622,000 at the end of the year. The decrease is attributed to distributions and withdrawals exceeding total additions from net investment income and contributions. The...Show More
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial performance of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, which is a defined contribution retirement plan for its employees. The plan includes a variety of investment options and is subject to ERISA provisions. The financial statements, audited by Withum Smith + Brown, PC, indicate that the plan's net assets available for benefits decreased from $62,527,000 at the beginning of the year to $60,622,000 at the end of the year. The decrease is attributed to distributions and withdrawals exceeding total additions from net investment income and contributions. The plan's investments are held in the Savings Plan Master Trust, which includes mutual funds, company stock, money market funds, and other assets. The report, signed by Senior Vice President and Treasurer Sandra Ramos-Alves on June 25, 2024, confirms the plan's compliance with U.S. GAAP and its tax-exempt status under the Code.
領先的藥品公司施貴寶（BMY.US）已向證券交易委員會提交了其截至2023年12月31日財政年度的年度11-K表格。該報告詳細說明了施貴寶員工激勵儲蓄計劃的財務表現，這是一項定期繳款的養老金計劃。該計劃包括各種投資選項，受ERISA規定的約束。由Withum Smith + Brown註冊會計師事務所進行審計的財務報表顯示，計劃的可供福利淨資產從年初的6,252.7萬美元下降到年末的6,062.2萬美元。這種下降是由於發放和提款超過了從淨投資收益和貢獻中總和的增加。計劃的投資被保留在儲蓄計劃主託管中，其中包括共同基金、公司股票、貨幣市場基金和其他資產。由Senior Vice President兼財務總監桑德拉·拉莫斯-阿爾維斯在2024年6月25日簽署的報告證實了該計劃符合美國普通會計準則和其根據法免稅的地位。
領先的藥品公司施貴寶（BMY.US）已向證券交易委員會提交了其截至2023年12月31日財政年度的年度11-K表格。該報告詳細說明了施貴寶員工激勵儲蓄計劃的財務表現，這是一項定期繳款的養老金計劃。該計劃包括各種投資選項，受ERISA規定的約束。由Withum Smith + Brown註冊會計師事務所進行審計的財務報表顯示，計劃的可供福利淨資產從年初的6,252.7萬美元下降到年末的6,062.2萬美元。這種下降是由於發放和提款超過了從淨投資收益和貢獻中總和的增加。計劃的投資被保留在儲蓄計劃主託管中，其中包括共同基金、公司股票、貨幣市場基金和其他資產。由Senior Vice President兼財務總監桑德拉·拉莫斯-阿爾維斯在2024年6月25日簽署的報告證實了該計劃符合美國普通會計準則和其根據法免稅的地位。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息